Real-world retrospective analysis of over 29,000 patients performing INR home monitoring for warfarin therapy shows excellent time in therapeutic range. Point-of-care, home international normalized ... — Patients receiving long-term, steady-dose warfarin therapy who have had stable international normalized ratios (INRs) for at least 6 months can safely go 12 weeks between dose ...
Many patients with good INR control on warfarin won’t maintain a high time in therapeutic range (TTR) even a year later, making past TTR a poor predictor of clinical outcomes in patients with A-fib, a ... The American Journal of Managed Care: STABLE Results: Warfarin Home Monitoring Achieves Excellent INR Control Nature: Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects Nature: Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized ... Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized ...
